A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
Karthik Ananthasubramaniam, Robert Weiss, Bruce McNutt, Barbara Klauke, Kathleen Feaheny, Stan BukofzerVolume:
19
Language:
english
Pages:
11
DOI:
10.1007/s12350-011-9508-3
Date:
April, 2012
File:
PDF, 333 KB
english, 2012